WhiteOak Capital Pharma and Healthcare Fund
WhiteOak Capital Pharma and Healthcare Fund (Direct, Growth): saplin Score 8.5/10 (Strong) among 14 Sectoral/Thematic funds. 1Y return 26.3%, expense ratio 1.04%. Returns that beat most peers, but higher costs than most peers. NAV ₹18.37 on 11 Nov 2026.
Loading the full analysis…